Arca
Skip to content

TERT: Telomerase reverse transcriptase

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes.

  • Drugs that act on it: 2
  • With a US drug page: 2
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
ImetelstatApprovedTelomerase reverse transcriptase inhibitorInhibitor—
Imetelstat sodiumApprovedTelomerase reverse transcriptase inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Dyskeratosis congenita, autosomal dominant 2
0.86
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
0.81
Dyskeratosis congenita
0.80
Autosomal recessive dyskeratosis congenita 4
0.71
Melanoma, cutaneous malignant, susceptibility to, 9
0.65
Prostate carcinoma
0.64

Drugs and mechanisms are from ChEMBL CHEMBL2916 (CC BY-SA 3.0). Gene name, function (UniProt O14746, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.